Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images

Journal of Psychopharmacology

Volumn 26, Issue 10, 2012, Pages 1289-1298

  Ballard, Michael E ^a   Bedi, Gillinder ^a,b   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

behavior; cannabinoids; drug abuse; drugs; emotions; facial emotion recognition; humans; Tetrahydrocannabinol

Indexed keywords

DRONABINOL;

ADULT; AFFECT; ANGER; ARTICLE; BEHAVIORAL RESEARCH; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; EMOTIONALITY; FACIAL EXPRESSION; FEAR; FEMALE; HAPPINESS; HUMAN; HUMAN EXPERIMENT; MALE; MOOD CHANGE; NORMAL HUMAN; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RECOGNITION; TASK PERFORMANCE;

ADOLESCENT; ADULT; AFFECTIVE SYMPTOMS; CANNABINOID RECEPTOR AGONISTS; CHICAGO; DOUBLE-BLIND METHOD; DRUG USERS; EXPRESSED EMOTION; FACIAL EXPRESSION; FEMALE; HALLUCINOGENS; HUMANS; MALE; PHOTIC STIMULATION; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, CANNABINOID, CB1; RECOGNITION (PSYCHOLOGY); REINFORCEMENT, SOCIAL; TETRAHYDROCANNABINOL; YOUNG ADULT;

EID: 84866252374     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112446530     Document Type: Article

References (65)

1. Adolphs R, Tranel D, Damasio H, et al. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature. 1994 ; 372: 669-672
2. Diagnostic and Statistical Manual of Mental Disorders. 1994 ) Diagnostic and Statistical Manual of Mental Disorders. 4 ed. Washington, DC: American Psychiatric Association. Washington, DC: American Psychiatric Association ; 1994
3. Bambico FR, Duranti A, Tontini A, et al. Endocannabinoids in the treatment of mood disorders: Evidence from animal models. Curr Pharm Des. 2009 ; 15: 1623-1646
4. Bedi G, Hyman D, de Wit H. Is ecstasy an 'Empathogen'? Effects of +/-3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry. 2010 ; 68: 1134-1140
5. Bedi G, Phan KL, Angstadt M, et al. Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl). 2009 ; 207: 73-83
6. Bhattacharyya S, Morrison PD, Fusar-Poli P, et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010 ; 35: 764-774
7. Blair RJ, Curran HV. Selective impairment in the recognition of anger induced by diazepam. Psychopharmacology (Berl). 1999 ; 147: 335-338
8. Borrill JA, Rosen BK, Summerfield AB. The influence of alcohol on judgement of facial expression of emotion. Br J Med Psychol. 1987 ; 60: 71-77
9. Browning M, Reid C, Cowen PJ, et al. A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol. 2007 ; 21: 684-690
10. Chait LD, Fischman MW, Schuster CR. 'Hangover' effects the morning after marijuana smoking. Drug Alcohol Depend. 1985 ; 15: 229-238
11. Cinciripini PM, Robinson JD, Carter BL, et al. The effects of smoking deprivation and nicotine administration on emotional reactivity. Nicotine Tob Res. 2006 ; 8: 379-392
12. Cooper ZD, Haney M. Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence. Int Rev Psychiatry. 2009 ; 21: 104-112
13. Cornelius JR, Aizenstein HJ, Hariri AR. Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression. Addict Behav. 2010 ; 35: 644-646
14. Coupland NJ, Singh AJ, Sustrik RA, et al. Effects of diazepam on facial emotion recognition. J Psychiatry Neurosci. 2003 ; 28: 452-463
15. Craig LC, Attwood AS, Benton CP, et al. Effects of acute alcohol consumption and alcohol expectancy on processing of perceptual cues of emotional expression. J Psychopharmacol. 2009 ; 23: 258-265
16. Del-Ben CM, Ferreira CA, Sanchez TA, et al. Effects of diazepam on BOLD activation during the processing of aversive faces. J Psychopharmacol. 2011 ; 26: 443-451
17. Donohue KF, Curtin JJ, Patrick CJ, et al. Intoxication level and emotional response. Emotion. 2007 ; 7: 103-112
18. Doty P, de Wit H. Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers. Psychopharmacology (Berl). 1995 ; 118: 19-27
19. D'Souza DC, Perry E, MacDougall L, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology. 2004 ; 29: 1558-1572
20. D'Souza DC, Ranganathan M, Braley G, et al. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology. 2008 ; 33: 2505-2516
21. Ekman P, Friesen WV Palo Alto, CA: Consulting Psychologists Press ; 1976
22. Fischman MW, Foltin RW. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict. 1991 ; 86: 1563-1570
23. Folstein MF, Luria R. Reliability, validity, and clinical application of the visual analog mood scale. Psychol Med. 1973 ; 3: 8
24. Fusar-Poli P, Crippa JA, Bhattacharyya S, et al. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009 ; 66: 95-105
25. Garcia-Gutierrez MS, Manzanares J. The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines. J Psychopharmacol. 2010 ; 24: 757-765
26. Gilman JM, Ramchandani VA, Davis MB, et al. Why we like to drink: A functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol. J Neurosci. 2008 ; 28: 4583-4591
27. Gospic K, Gunnarsson T, Fransson P, et al. Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology (Berl). 2008 ; 197: 295-307
28. Gruber SA, Rogowska J, Yurgelun-Todd DA. Altered affective response in marijuana smokers: An FMRI study. Drug Alcohol Depend. 2009 ; 105: 139-153
29. Harmer CJ, Bhagwagar Z, Perrett DI, et al. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology. 2003 ; 28: 148-152
30. Harmer CJ, Heinzen J, O'Sullivan U, Ayres RA, et al. Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers. Psychopharmacology (Berl). 2008 ; 199: 495-502
31. Harmer CJ, Mackay CE, Reid CB, et al. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry. 2006 ; 59: 816-820
32. Harmer CJ, O'Sullivan U, Favaron E, et al. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry. 2009 ; 166: 1178-1184
33. Harmer CJ, Shelley NC, Cowen PJ, et al. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry. 2004 ; 161: 1256-1263
34. Horder J, Browning M, Di Simplicio M, et al. Effects of 7 days treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing. J Psychopharmacol. 2011 ; 26: 125-132
35. Horder J, Cowen PJ, Di Simplicio M, et al. Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology (Berl). 2009 ; 205: 85-91
36. Horder J, Harmer CJ, Cowen PJ, et al. Reduced neural response to reward following 7 days treatment with the cannabinoid CB(1) antagonist rimonabant in healthy volunteers. Int J Neuropsychopharmacol. 2010 ; 13: 1103-1113
37. Ilan AB, Gevins A, Coleman M, et al. Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behav Pharmacol. 2005 ; 16: 487-496
38. Karschner EL, Darwin WD, McMahon RP, et al. Subjective and physiological effects after controlled Sativex and oral THC administration. Clin Pharmacol Ther. 2011 ; 89: 400-407
39. Katona I, Rancz EA, Acsady L, et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of gabaergic transmission. J Neurosci. 2001 ; 21: 9506-9518
40. Kirk JM, Doty P, de Wit H. Effects of expectancies on subjective responses to oral delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav. 1998 ; 59: 287-293
41. Knowles SK, Duka T. Does alcohol affect memory for emotional and non-emotional experiences in different ways?. Behav Pharmacol. 2004 ; 15: 111-121
42. Lang PJ, Bradley MM, Cuthbert BN International Affective Picture System (IAPS): Technical Manual and Affective Ratings. Gainesville, FL: NIMH Center for the Study of Emotion and Attention, University of Florida ; 1999
43. Lang PJ, Greenwald MK, Bradley MM, et al. Looking at pictures: Affective, facial, visceral, and behavioral reactions. Psychophysiology. 1993 ; 30: 261-273
44. Mackie K Cannabinoids. Handbook of Experimental Pharmacology. Pertwee RG, ed. Heidelberg: Springer-Verlag ; 2005
45. Martin WR, Sloan JW, Sapira JD, et al. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971 ; 12: 245-258
46. Metrik J, Rohsenow DJ, Monti PM, et al. Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol. 2009 ; 17: 217-225
47. Moreira FA, Wotjak CT. Cannabinoids and anxiety. Curr Top Behav Neurosci. 2010 ; 2: 429-450
48. Ohman A. The role of the amygdala in human fear: Automatic detection of threat. Psychoneuroendocrinology. 2005 ; 30: 953-958
49. Patrick CJ, Berthot BD, Moore JD. Diazepam blocks fear-potentiated startle in humans. J Abnorm Psychol. 1996 ; 105: 89-96
50. Paulus MP, Feinstein JS, Castillo G, et al. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch Gen Psychiatry. 2005 ; 62: 282-288
51. Phan KL, Angstadt M, Golden J, et al. Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci. 2008 ; 28: 2313-2319
52. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology. 2010 ; 35: 192-216
53. Strassman RJ, Qualls CR, Uhlenhuth EH, et al. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry. 1994 ; 51: 98-108
54. Stritzke WG, Patrick CJ, Lang AR. Alcohol and human emotion: A multidimensional analysis incorporating startle-probe methodology. J Abnorm Psychol. 1995 ; 104: 114-122
55. Surcinelli P, Codispoti M, Montebarocci O, et al. Facial emotion recognition in trait anxiety. J Anxiety Disord. 2006 ; 20: 110-117
56. Trevisani DP, Johnson SL, Carver CS. Positive mood induction and facial affect recognition among students at risk for mania. Cognit Ther Res. 2008 ; 32: 639
57. Vuilleumier P, Pourtois G. Distributed and interactive brain mechanisms during emotion face perception: Evidence from functional neuroimaging. Neuropsychologia. 2007 ; 45: 174-194
58. Wachtel SR, de Wit H. Naltrexone does not block the subjective effects of oral delta-9-tetrahydrocannabinol in humans. Drug Alcohol Depend. 2000 ; 59: 251-260
59. Wachtel SR, Elsohly MA, Ross SA, et al. Comparison of the subjective effects of delta-9-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl). 2002 ; 161: 331-339
60. Wardle MC, de Wit H. Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl). 2012 ; 220: 143-153
61. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol. 1988 ; 54: 1063-1070
62. Young AW, Rowland D, Calder AJ, et al. Facial expression megamix: Tests of dimensional and category accounts of emotion recognition. Cognition. 1997 ; 63: 271-313
63. Zanettini C, Panlilio LV, Alicki M, et al. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci. 2011 ; 5: 57
64. Zangara A, Blair RJ, Curran HV. A comparison of the effects of a beta-adrenergic blocker and a benzodiazepine upon the recognition of human facial expressions. Psychopharmacology (Berl). 2002 ; 163: 36-41
65. Zuardi AW, Shirakawa I, Finkelfarb E, et al. Action of cannabidiol on the anxiety and other effects produced by delta-9-thc in normal subjects. Psychopharmacology (Berl). 1982 ; 76: 245-250